Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC
Updated on: October 05,2025
Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC
Updated on:October 05,2025
